Scientists Discover Why Malaria Mosquitoes Like People With Malaria

Article

Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria. Researchers from Stockholm University, the Swedish University of Agricultural Sciences and KTH Royal Institute of Technology have discovered why. The findings can lead to new ways to fight malaria without using poisonous chemicals. The results will be published in the next issue of the journal Science.

The research team at Stockholm University: Noushin Emami, Ingrid Faye and Bo Lindberg. Courtesy of Anna-Karin Landin/Stockholm University
 
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria. Researchers from Stockholm University, the Swedish University of Agricultural Sciences and KTH Royal Institute of Technology have discovered why. The findings can lead to new ways to fight malaria without using poisonous chemicals. The results will be published in the next issue of the journal Science.

"The malaria parasite produces a molecule, HMBPP, which stimulates the human red blood cells to release more carbon dioxide and volatile compounds with an irresistible smell to malaria mosquitoes. The mosquito also eats more blood," says Ingrid Faye at Stockholm University.

Faye and her colleagues from the Swedish University of Agricultural Sciences and KTH Royal Institute of Technology discovered that most malaria mosquitoes, were attracted by HMBPP-blood, even at very low concentrations. The mosquitoes are also attracted more quickly and drink more blood. Moreover, these mosquitoes acquire a more severe malaria infection, i.e., higher numbers of parasites are produced. This indicates that the extra nutrients from the larger meal of blood are used to produce more parasites, researchers believe. Neither humans nor mosquitoes use HMBPP themselves, but the parasite needs the substance to be able to grow.

"HMBPP is a way for the malaria parasite to hail a cab, a mosquito, and successfully transfer to the next host," Noushin Emami explains. She has worked over three years in the project and has performed a large part of the complicated practical work with the parasites and the mosquitoes at Stockholm University and at the Swedish University of Agricultural Sciences in Alnarp.

"This seems to be a well-functioning system, developed over millions of years, which means that the malaria parasite can survive and spread to more people without killing the hosts," says Faye.

These results may be useful in combatting malaria. Today the most efficient way is to use mosquito nets and insecticides to prevent people being bitten. Resistance against the insecticides require new control methods to be developed to tackle the mosquitoes. In addition, medicines, even the drug awarded with the 2015 Nobel Prize, become progressively inefficient when the parasite becomes resistant to them and new drugs must be developed constantly. A vaccine seems far away, Faye says. A major step forward in the fight against malaria would be to create a trap that uses the parasite's own system for attracting malaria mosquitoes.

The article "A key malaria metabolite modulates vector blood seeking, feeding and susceptibility to infection" was published in Science online on Feb. 9, 2017.

Source: Stockholm University

Recent Videos
 Darren Goff, executive director of hospitality services at Cameron Memorial Community Hospital in Angola, Indiana.
Isis Lamphier, MPH, MHA, CIC; Tori Whitacre Martonicz, MA; and Heather Stoltzfus, MPH, RN, CIC, at APIC Conference and Expo 2024 (Photo courtesy of Tori Whitacre Martonicz)
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
Related Content